Table 1 summarizes potential therapeutic opportunities in different targeting options, such as initiating autophagy, mitophagy, lysosomes, LRRK2 inhibition, and microRNA (miRNA) targeting autophagy in PD. The gene discussed is LRRK2; the disease is Parkinson disease.